Partial or total penectomy with inguinal and/or pelvic lymph node dissection + PEMBROLIZUMAB + PYRUVATE CARBOXYLASE, MITOCHONDRIAL for penile neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Apr 2024: Trial registered, NCT06353906
  2. 13 Aug 2024: Trial started, NCT06353906

The trials

NCT06353906: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer

State
Under way
Phase
Phase 2
People
27 planned
Started
13 Aug 2024
Primary completion
14 Oct 2026
Arms
Induction chemo-immunotherapy combination followed by consolidative surgical resection
Results
None posted
  1. 9 Apr 2024: Trial registered
  2. 13 Aug 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.